Ishikawa T - Search Results

1

Potential of dendritic-cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole-limpet-hemocyanin-pulsed, donor-derived dendritic-cell vaccine for acute myeloid leukemia.

Kitawaki T, Kadowaki N, Kondo T, Ishikawa T, Ichinohe T, Teramukai S, Fukushima M, Kasai Y, Maekawa T, Uchiyama T. Kitawaki T, et al. Among authors: ishikawa t. Am J Hematol. 2008 Apr;83(4):315-7. doi: 10.1002/ajh.21127. Am J Hematol. 2008. PMID: 18081032 Free article.

2

[Significance of soluble interleukin-2 receptor alpha chain in the management of patients with malignant lymphoma: a multi-center study].

Ohno H, Ishikawa T, Kitajima H, Nomura S, Suzuki T, Konishi H, Ohno Y, Onishi R, Konaka Y, Arima N, Doi S, Nasu K, Takahashi T, Tsudo M, Fukuhara S, Uchiyama T. Ohno H, et al. Among authors: ishikawa t. Rinsho Ketsueki. 2002 Mar;43(3):170-5. Rinsho Ketsueki. 2002. PMID: 11979748 Japanese.

3

[Successful treatment of chronic myelogenous leukemia with extramedullary megakaryoblastic tumor by allogeneic bone marrow transplantation (from an unrelated donor)].

Jinnai M, Hishizawa M, Kitawaki T, Imada K, Ishikawa T, Ohno H, Uchiyama T, Ohno T. Jinnai M, et al. Among authors: ishikawa t. Nihon Naika Gakkai Zasshi. 2002 May 10;91(5):1598-600. doi: 10.2169/naika.91.1598. Nihon Naika Gakkai Zasshi. 2002. PMID: 12082755 Japanese. No abstract available.

4

Myasthenia gravis after allogeneic bone marrow transplantation treated with mycophenolate mofetil monitored by peripheral blood OX40+ CD4+ T cells.

Kotani A, Takahashi A, Koga H, Morita R, Fukuyama H, Ichinohe T, Ishikawa T, Hori T, Uchiyama T. Kotani A, et al. Among authors: ishikawa t. Eur J Haematol. 2002 Nov-Dec;69(5-6):318-20. doi: 10.1034/j.1600-0609.2002.02789.x. Eur J Haematol. 2002. PMID: 12460238

5

Successful treatment with paclitaxel of advanced AIDS-associated Kaposi's sarcoma.

Kobayashi M, Takaori-Kondo A, Shindo K, Mizutani C, Ishikawa T, Uchiyama T. Kobayashi M, et al. Among authors: ishikawa t. Intern Med. 2002 Dec;41(12):1209-12. doi: 10.2169/internalmedicine.41.1209. Intern Med. 2002. PMID: 12521218 Free article.

6

Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response.

Ukyo N, Hori T, Yanagita S, Ishikawa T, Uchiyama T. Ukyo N, et al. Among authors: ishikawa t. Immunology. 2003 Jun;109(2):226-31. doi: 10.1046/j.1365-2567.2003.01648.x. Immunology. 2003. PMID: 12757617 Free PMC article.

7

[Reduced-intensity hematopoietic stem cell transplantation and donor lymphocyte infusions for chronic myeloid leukemia].

Ichinohe T, Ishikawa T. Ichinohe T, et al. Among authors: ishikawa t. Nihon Rinsho. 2003 Sep;61(9):1573-8. Nihon Rinsho. 2003. PMID: 14515726 Review. Japanese.

8

Current status of therapeutic approaches to adult T-cell leukemia.

Ishikawa T. Ishikawa T. Int J Hematol. 2003 Nov;78(4):304-11. doi: 10.1007/BF02983554. Int J Hematol. 2003. PMID: 14686487 Review.

9

Retroviral transduction of acute myeloid leukaemia-derived dendritic cells with OX40 ligand augments their antigen presenting activity.

Yanagita S, Hori T, Matsubara Y, Ishikawa T, Uchiyama T. Yanagita S, et al. Among authors: ishikawa t. Br J Haematol. 2004 Feb;124(4):454-62. doi: 10.1046/j.1365-2141.2003.04791.x. Br J Haematol. 2004. PMID: 14984494 Free article.

10

Primary myelofibrosis terminated in basophilic leukemia and successful allogeneic bone marrow transplantation.

Sugimoto N, Ishikawa T, Gotoh S, Shinzato I, Matsushita A, Nagai K, Ohgoh N, Takahashi T. Sugimoto N, et al. Among authors: ishikawa t. Int J Hematol. 2004 Aug;80(2):183-5. doi: 10.1532/ijh97.03153. Int J Hematol. 2004. PMID: 15481449

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,620 results

Search Page